What Is Melanin-Concentrating Hormone? Definition and What Research Reports
Melanin-concentrating hormone (MCH) is a cyclic 19-amino-acid neuropeptide made mainly by neurons in the lateral hypothalamus and zona incerta, acting through the G protein-coupled receptors MCHR1 and, in some species, MCHR2. In peptide research the term usually refers to this neuropeptide system rather than a therapeutic product. Published animal work has linked MCH signalling to feeding, sleep, hippocampal and septal circuit activity, anxiety-related behaviour and reproductive axis signalling; human work has measured MCH in peripheral circulation.
Definition
Melanin-concentrating hormone (MCH) is a cyclic neuropeptide — 19 amino acids in mammals, closed by a disulfide bridge — produced mainly by a discrete population of neurons in the lateral hypothalamic area and the incerto-hypothalamic region, which send projections throughout the brain. It is cleaved from a larger precursor protein (pro-MCH) and signals through class A G protein-coupled receptors known as MCH receptor 1 (MCHR1) and MCH receptor 2 (MCHR2). The name is historical: the peptide was first characterised in fish, where it acts on skin pigment cells to aggregate melanin granules and lighten body colour. In mammals that pigmentary role is not its main function; instead MCH is studied as a central neuromodulator of feeding, arousal and state-dependent brain activity.
This page is for educational purposes only and is not medical advice; consult a licensed physician for any health question. Nothing here describes how any substance should be used.
What Class of Molecule It Is, and Where It Comes From
MCH belongs to the family of hypothalamic neuropeptides — signalling molecules released by neurons rather than by classical endocrine glands, although MCH has also been detected outside the brain. A 2018 comparative review of the MCH system in human, rodent and avian brain described the anatomy of MCH-producing neurons and their widespread projections across species (PMID 29992190). Its receptors are unevenly distributed across species: a 2002 genomics study reported species-specific gene expression patterns for MCH receptor subtypes 1 and 2, noting that a functional MCHR2 is present in some mammals but not others (PMID 12036292). That species difference is one reason findings in rodents are not assumed to transfer directly to humans.
Receptor handling has also been examined at the cell-biology level. A 2024 study reported that MCH receptor 1, after internalisation, was discarded by cells via exosomes rather than being recycled in the conventional way (PMID 38604071).
| Attribute | Description |
|---|---|
| Molecule class | Cyclic neuropeptide (19 amino acids in mammals), cleaved from pro-MCH |
| Main source | Neurons of the lateral hypothalamus and zona incerta; projections brain-wide (PMID 29992190) |
| Receptors | MCHR1 and MCHR2, with species-specific expression (PMID 12036292) |
| Original description | Pigment-granule aggregation in fish skin; name predates the mammalian work |
| Research themes | Feeding, sleep and arousal, memory circuits, anxiety-related behaviour, reproductive axis |
How the Term Is Used in Peptide Research
In the peptide literature, "melanin-concentrating hormone" is used in three overlapping ways. First, as the molecule itself — the endogenous peptide measured in tissue or plasma, or applied experimentally to neurons and animals in laboratory studies. Second, as the name of a neural system: phrases such as "MCH neurons" or "the MCH system" describe the hypothalamic cell population and its projections, which researchers manipulate with genetic, chemogenetic or optogenetic tools. Third, as a receptor target: much pharmacology in this area concerns MCHR1 ligands rather than the peptide, because the receptor is more tractable for small-molecule work.
MCH is frequently discussed alongside orexin (hypocretin), a different lateral-hypothalamic peptide system with largely opposing effects on arousal. A 2018 electrophysiology study characterised the intrinsic membrane properties of MCH and orexin neurons in adolescent rats, comparing the two populations directly (PMID 29662440).
Is MCH a "research peptide" in the commercial sense?
MCH is not an approved drug and is not a product with an established human use. It appears in the literature as a laboratory reagent and as an endogenous signalling molecule under investigation. Published human data are largely observational or analytical rather than interventional: a 2017 study in The Journal of Endocrinology examined MCH in peripheral circulation in humans, addressing whether and in what form the peptide is detectable in blood (PMID 28053003).
Doing the math on a vial? The PeptideU app does reconstitution, units and dilution for you.
Try it freeWhat the Published Literature Reports
Feeding and reward
Feeding has been the most-studied function. A 2005 study reported that melanin-concentrating hormone enhanced sucrose intake in animals, linking MCH signalling to consumption of a palatable solution rather than to caloric need alone (PMID 15870910). More recently, a 2025 study reported that MCH promoted feeding through the lateral septum, identifying a circuit outside the classical hypothalamic feeding nodes (PMID 39389251).
Sleep and arousal
A 2011 review in Frontiers in Neurology asked whether MCH should be considered "a new sleep factor", summarising evidence that MCH neurons are active in relation to sleep states and that MCH signalling has been associated with sleep regulation (PMID 21516258).
Memory circuits and septal activity
A 2022 paper in Nature Neuroscience reported that hypothalamic MCH regulated hippocampus–dorsolateral septum activity, placing the peptide within circuits associated with spatial and contextual processing (PMID 34980924).
Anxiety-related behaviour and gut function: What Studies Report
Not all reported effects are neutral. Researchers in a 2022 mouse study reported that melanin-concentrating hormone promoted anxiety-like behaviour and intestinal dysfunction via the basolateral amygdala (PMID 36016574). In a separate line of work in fish, a 2022 study reported that MCH interfered with the hypothalamic–pituitary–gonad axis in the Mozambique tilapia, indicating interactions with reproductive signalling in that species (PMID 34838935). These are animal findings in specific experimental contexts and were not human safety assessments.
Neuroinflammation
A 2024 study in the Journal of Neuroinflammation reported that melanin concentrating hormone regulated JNK/ERK signalling and alleviated neuroinflammation induced by influenza A virus infection in an animal model (PMID 39390522).
Limits of the Current Evidence
- Most functional findings come from rodents or fish; the study designs reported above were preclinical, and species differences in receptor expression are documented (PMID 12036292).
- Effects reported for MCH depend heavily on the brain region targeted — feeding via the lateral septum in one study (PMID 39389251) versus anxiety-related effects via the basolateral amygdala in another (PMID 36016574) — so "what MCH does" is not a single answer.
- Human data are limited; the available circulation study addressed detection and measurement rather than clinical outcomes (PMID 28053003).
- No dosing regimen for humans is established in the cited literature, and none is described on this page.
Tracking research? Log entries with dates, lots and notes — records, never plans.
Get the appRelated Terms
- Pro-MCH — the precursor protein from which MCH is cleaved.
- MCHR1 / MCHR2 — the two G protein-coupled receptors for MCH, with species-specific expression (PMID 12036292).
- Orexin / hypocretin — a distinct lateral-hypothalamic peptide system studied alongside MCH neurons (PMID 29662440).
- Lateral hypothalamic area — the principal source region of MCH neurons (PMID 29992190).
References
- Melanin-concentrating hormone enhances sucrose intake (International Journal of Molecular Medicine, 2005)
- Melanin-concentrating hormone in peripheral circulation in the human (The Journal of Endocrinology, 2017)
- Melanin-concentrating hormone promotes anxiety and intestinal dysfunction via basolateral amygdala in mice (Frontiers in Pharmacology, 2022)
- Melanin-concentrating hormone interferes with the hypothalamic-pituitary-gonad axis in the Mozambique tilapia (Comparative Biochemistry and Physiology Part A, 2022)
- Hypothalamic melanin-concentrating hormone regulates hippocampus-dorsolateral septum activity (Nature Neuroscience, 2022)
- Melanin-concentrating hormone: a new sleep factor? (Frontiers in Neurology, 2011)
- Melanin-concentrating hormone promotes feeding through the lateral septum (Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2025)
- The Melanin-concentrating Hormone System in Human, Rodent and Avian Brain (Open Medicine, 2018)
- Melanin-concentrating hormone receptor 1 is discarded by exosomes after internalization (Biochemical and Biophysical Research Communications, 2024)
- Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression (Genomics, 2002)
- Electrophysiological Properties of Melanin-Concentrating Hormone and Orexin Neurons in Adolescent Rats (Frontiers in Cellular Neuroscience, 2018)
- Melanin concentrating hormone regulates the JNK/ERK signaling pathway to alleviate influenza A virus infection-induced neuroinflammation (Journal of Neuroinflammation, 2024)
Frequently asked questions
What does melanin-concentrating hormone actually do?▾
There is no single answer. In mammals it is studied as a central neuromodulator. Researchers reported that MCH enhanced sucrose intake (PMID 15870910), promoted feeding through the lateral septum (PMID 39389251), and regulated hippocampus–dorsolateral septum activity (PMID 34980924). A review also examined whether MCH should be regarded as a sleep factor (PMID 21516258). Effects depend on the circuit studied.
Why is it called a "melanin-concentrating" hormone?▾
The name comes from its original description in fish, where the peptide causes pigment granules in skin cells to aggregate, lightening body colour. In mammals that pigmentary role is not the focus of research; a comparative review described MCH-producing neurons and their projections in human, rodent and avian brain instead (PMID 29992190).
What receptors does MCH act on?▾
MCH signals through G protein-coupled receptors MCHR1 and MCHR2. A genomics study reported species-specific gene expression of the two subtypes, meaning a functional MCHR2 is present in some species and not others (PMID 12036292). A separate study reported that MCHR1, after internalisation, was discarded by cells via exosomes (PMID 38604071).
Has melanin-concentrating hormone been measured in humans?▾
Yes, analytically. A 2017 study in The Journal of Endocrinology examined melanin-concentrating hormone in peripheral circulation in humans, addressing detection and measurement of the peptide in blood (PMID 28053003). That work was not an interventional trial, and the cited literature does not establish any human dosing regimen or clinical outcome.
What adverse or unwanted effects have studies reported?▾
In animals, researchers reported that MCH promoted anxiety-like behaviour and intestinal dysfunction via the basolateral amygdala in mice (PMID 36016574), and that MCH interfered with the hypothalamic–pituitary–gonad axis in the Mozambique tilapia (PMID 34838935). These were preclinical findings in specific experimental contexts, not human safety assessments.
How does MCH relate to orexin?▾
Both are neuropeptides made in the lateral hypothalamus, and they are commonly studied together because of their contrasting roles in arousal. A 2018 study compared the electrophysiological properties of MCH and orexin neurons in adolescent rats, characterising the intrinsic membrane behaviour of each population (PMID 29662440).
Is MCH studied in anything other than feeding and sleep?▾
Yes. A 2024 study reported that melanin concentrating hormone regulated JNK/ERK signalling and alleviated neuroinflammation induced by influenza A virus infection in an animal model (PMID 39390522). Other work has placed MCH within memory-related circuits, reporting regulation of hippocampus–dorsolateral septum activity (PMID 34980924).
Track it. Calculate it. Actually understand it.
References
This page summarises published research for education — it is not medical advice, and nothing here is a recommendation to use, purchase, or dose any substance. Study parameters described are what researchers reported, not instructions. Consult a qualified clinician before any health decision.